Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Heme Oxygenase-1 Differentially Controls Pigmentation in Physiological and Pathological Melanogenesis.

Pigment cell & melanoma research·2026

Same author

Polyclonal regeneration of mouse bone marrow endothelial cells after irradiative conditioning.

Cell reports·2026

Same author

Heme oxygenase-1 does not affect formation of stress granules.

Biochemical and biophysical research communications·2026

Same author

Advances in endothelial cell targeting by AAV vectors.

Acta biochimica Polonica·2026

Same author

S-nitrosation in endothelium: different outcomes of NRF2 and GSNOR loss.

Free radical biology & medicine·2025

Same author

Effect of heme oxygenase-1 on the expression of interferon-stimulated genes.

Journal of inflammation (London, England)·2025

Search research articles

Related Experiment Video

Updated: May 29, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Stem cells in pharmaceutical biotechnology.

Ewa K Zuba-Surma¹, Alicja Józkowicz, Józef Dulak

¹Department of Medical Biotechnology, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. ewa.zuba-surma@uj.edu.pl

Current Pharmaceutical Biotechnology

|September 10, 2011

Summary

Embryonic stem cells (ESC) and inducible pluripotent stem cells (iPS) offer potential in drug development and disease modeling. These stem cells can create advanced physiological models for evaluating drug safety and efficacy, leading to safer therapeutics.

More Related Videos

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Published on: September 25, 2016

Related Experiment Videos

Last Updated: May 29, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Published on: September 25, 2016

Area of Science:

Biotechnology
Regenerative Medicine
Pharmacology

Background:

Stem cells, including embryonic stem cells (ESC) and inducible pluripotent stem cells (iPS), are crucial for organ regeneration due to their proliferative and differentiation potential.
Current preclinical drug testing models using primary or immortalized cell lines have limitations in accessibility and in vivo relevance.
Human ESC applications are increasingly focused on drug development and disease modeling rather than direct regenerative therapies.

Purpose of the Study:

To review the applications of stem cells in pharmaceutical biotechnology.
To explore the use of pluripotent stem cells in creating physiological models for drug evaluation.
To discuss the potential of stem cells in understanding disease pathogenesis and developing targeted therapies.

Main Methods:

Review of current literature on stem cell applications in pharmaceutical biotechnology.
Discussion of pluripotent stem cell-derived models for pharmacological, metabolic, and toxicity evaluations.
Exploration of stem cells as targets for drug activity and disease mechanism elucidation.

Main Results:

Stem cells can generate renewable human cell models with functional similarities to in vivo counterparts, advancing cell-based assays.
Utilizing stem cells as physiological targets can enhance target validation and efficacy assessment for drug development.
Stem cell-derived models offer insights into disease pathogenesis, potentially leading to novel therapeutic strategies.

Conclusions:

Stem cells are valuable tools in pharmaceutical biotechnology, particularly for drug development and disease modeling.
Patient-specific pluripotent stem cells can facilitate the development of targeted drug and cellular therapies.
Advancements in stem cell technology promise to improve drug safety, efficacy, and personalized medicine.